Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bylock

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2013
Plasminogen activator inhibitor-1 levels and activity decrease after intervention in patients with critical limb ischaemiaM Björck, M Lepkowska Eriksson, A Bylock, et al.
Lasers in Surgery and Medicine|January 1, 1992
Preliminary results of intraoperative excimer laser angioplasty: phase 1: an adjunct to coronary artery bypass surgeryO H Frazier, E B Diethrich, B Johansson, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2013
Plasminogen activator inhibitor-1 levels and activity decrease after intervention in patients with critical limb ischaemiaM Björck, M Lepkowska Eriksson, A Bylock, et al.
Lasers in Surgery and Medicine|January 1, 1992
Preliminary results of intraoperative excimer laser angioplasty: phase 1: an adjunct to coronary artery bypass surgeryO H Frazier, E B Diethrich, B Johansson, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
Pageof 4